Market Tracker

10/22 3:45am ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.46
Data as of Oct 21
 +0.04 / +2.82%
Today’s Change
1.11
Today|||52-Week Range
2.27
-29.47%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.42
Today’s open1.44
Day’s range-- - --
Volume855,797
Average volume (3 months)603,014
Market cap$213.9M
Dividend yield--
Data as of 10/21/2014

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+22.14%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...-0.10-1.36%
GALEGalena Biopharma Inc+0.09+4.92%
ALIMAlimera Sciences Inc-0.11-2.25%
AMPEAmpio Pharmaceutical...-0.30-7.50%
Data as of 4:02pm ET, 10/21/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Rick Gonzalez
President &
Chief Business Officer
Thomas H. Tulip
Corporate headquarters
Dublin, Ohio

Forecasts